USE OF RECIPIENT ENDOTHELIAL CELLS FOR ENHANCED VASCULARIZATION OF TISSUE AND TISSUEENGINEERED CONSTRUCT TRANSPLANTS

Details for Australian Patent Application No. 2002323526 (hide)

Owner PACGEN CELLCO LLC

Inventors REVAZOVA, Elena; SEBASTIAN, Jeff

Pub. Number AU-A-2002323526

PCT Number PCT/US02/27761

PCT Pub. Number WO2003/020955

Priority 60/316,441 31.08.01 US

Filing date 30 August 2002

Wipo publication date 18 March 2003

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/316,441 31.08.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-A-2002323526

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002323527-CLOSED-LOOP FOCAL POSITIONING SYSTEM AND METHOD

2002323525-METHOD AND SYSTEM FOR DOMAIN NAME REGISTRATION AND EMAIL BY PROXY